{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T07:05:52Z","timestamp":1792047952814,"version":"4.4.0"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","lrjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.leukres.2017.01.016","type":"journal-article","created":{"date-parts":[[2017,1,16]],"date-time":"2017-01-16T09:02:33Z","timestamp":1484557353000},"page":"18-22","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Clinical significance of isolated del(7p) in myeloid neoplasms"],"prefix":"10.1016","volume":"55","author":[{"given":"Hatice Deniz","family":"Gur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sa A.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenya","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shimin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Jeffrey","family":"Medeiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.leukres.2017.01.016_bib0005","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1182\/blood-2012-03-420489","article-title":"Revised international prognostic scoring system for myelodysplastic syndromes","volume":"120","author":"Greenberg","year":"2012","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.leukres.2017.01.016_bib0010","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1200\/JCO.2011.35.6394","article-title":"New comprehensive cytogenetic scoring system for primary myelodysplastic syndromes (MDS) and oligoblastic acute myeloid leukemia after MDS derived from an international database merge","volume":"30","author":"Schanz","year":"2012","journal-title":"J. Clin. Oncol."},{"issue":"12","key":"10.1016\/j.leukres.2017.01.016_bib0015","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1002\/cncr.23977","article-title":"Cytogenetic abnormalities in a series of 1,029 patients with primary myelodysplastic syndromes: a report from the US with a focus on some undefined single chromosomal abnormalities","volume":"113","author":"Pozdnyakova","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.leukres.2017.01.016_bib0020","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues Edited by International Agency for Research on Cancer","author":"Swerdlow","year":"2008"},{"issue":"1","key":"10.1016\/j.leukres.2017.01.016_bib0025","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/cncr.26279","article-title":"Better prognosis for patients with del(7q) than for patients with monosomy 7 in myelodysplastic syndrome","volume":"118","author":"Cordoba","year":"2012","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.leukres.2017.01.016_bib0030","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1182\/blood-2009-07-235358","article-title":"Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet","volume":"115","author":"Dohner","year":"2010","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.leukres.2017.01.016_bib0035","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/sj.leu.2403327","article-title":"Deletion of 7p or monosomy 7 in pediatric acute lymphoblastic leukemia is an adverse prognostic factor: a report from the Children\u2019s Cancer Group","volume":"18","author":"Heerema","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2017.01.016_bib0040","series-title":"An International System for Human Cytogenetic Nomenclature","author":"Shaffer","year":"2016"},{"issue":"8","key":"10.1016\/j.leukres.2017.01.016_bib0045","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.leukres.2014.05.015","article-title":"Clinically silent clonal cytogenetic abnormalities arising in patients treated for lymphoid neoplasms","volume":"38","author":"Tang","year":"2014","journal-title":"Leuk. Res."},{"issue":"7","key":"10.1016\/j.leukres.2017.01.016_bib0050","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/modpathol.2016.67","article-title":"Newly emerged isolated Del(7q) in patients with prior cytotoxic therapies may not always be associated with therapy-related myeloid neoplasms","volume":"29","author":"Goswami","year":"2016","journal-title":"Mod. Pathol."},{"issue":"8","key":"10.1016\/j.leukres.2017.01.016_bib0055","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/modpathol.2016.76","article-title":"Clinical significance of newly emerged isolated del(20q) in patients following cytotoxic therapies","volume":"29","author":"Yin","year":"2016","journal-title":"Mod. Pathol."},{"issue":"1","key":"10.1016\/j.leukres.2017.01.016_bib0060","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1309\/AJCPBADO22WXOFHJ","article-title":"Isolated del(5q) in patients following therapies for various malignancies may not all Be clinically significant","volume":"144","author":"Tang","year":"2015","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.leukres.2017.01.016_bib0065","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkw804","article-title":"A quantitative proteomics approach identifies ETV6 and IKZF1 as new regulators of an ERG-driven transcriptional network","author":"Unnikrishnan","year":"2016","journal-title":"Nucl. Acids Res."},{"issue":"1","key":"10.1016\/j.leukres.2017.01.016_bib0070","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/leu.2015.199","article-title":"Prognostic value of rare IKZF1 deletion in childhood B-cell precursor acute lymphoblastic leukemia: an international collaborative study","volume":"30","author":"Boer","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2017.01.016_bib0075","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1186\/s12885-016-2300-7","article-title":"Prognostic impact of IKZF1 deletion in adults with common B-cell acute lymphoblastic leukemia","volume":"16","author":"Yao","year":"2016","journal-title":"BMC Cancer"},{"issue":"9","key":"10.1016\/j.leukres.2017.01.016_bib0080","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.3324\/haematol.2015.124321","article-title":"Recurrent deletions of IKZF1 in pediatric acute myeloid leukemia","volume":"100","author":"de Rooij","year":"2015","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.leukres.2017.01.016_bib0085","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/sj.leu.2404076","article-title":"A novel and cytogenetically cryptic t(7;21)(p22;q22) in acute myeloid leukemia results in fusion of RUNX1 with the ubiquitin-specific protease gene USP42","volume":"20","author":"Paulsson","year":"2006","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.leukres.2017.01.016_bib0090","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1111\/j.1365-2141.2009.08039.x","article-title":"Molecular characterisation of a recurrent, semi-cryptic RUNX1 translocation t(7;21) in myelodysplastic syndrome and acute myeloid leukaemia","volume":"148","author":"Foster","year":"2010","journal-title":"Br. J. Haematol."}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212617300164?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212617300164?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T22:56:07Z","timestamp":1536101767000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212617300164"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":18,"alternative-id":["S0145212617300164"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2017.01.016","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical significance of isolated del(7p) in myeloid neoplasms","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2017.01.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}